Page last updated: 2024-11-12

n1-phenyl-3,5-dinitro-n4,n4-di-n-propylsulfanilamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N1-phenyl-3,5-dinitro-N4,N4-di-n-propylsulfanilamide: a potent, selective antimitotic agent against kinetoplastid parasites; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9910120
CHEMBL ID53153
MeSH IDM0458946

Synonyms (7)

Synonym
4-(dipropylamino)-3,5-dinitro-n-phenyl-benzenesulfonamide
gb-ii-5
4-(dipropylamino)-3,5-dinitro-n-phenylbenzenesulfonamide
CHEMBL53153
sulfamidas3
bdbm81744
n1-phenyl-3,5-dinitro-n4,n4-di-n-propylsulfanilamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Tubulin alpha-1A chainSus scrofa (pig)IC50 (µMol)23.20000.00672.160310.0000AID1799579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (30)

Assay IDTitleYearJournalArticle
AID522815Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID100412Inhibitory activity against Leishmania donovani amastigotes2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin.
AID211830Tested for toxicity against mice by intraperitoneal administration; No signs of toxicity2004Journal of medicinal chemistry, Mar-25, Volume: 47, Issue:7
Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
AID213842Inhibition of Leishmanial tubulin assembly2004Journal of medicinal chemistry, Mar-25, Volume: 47, Issue:7
Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
AID100424Inhibitory concentration against Leishmania donovani axenic amastigotes was determined in vitro2004Journal of medicinal chemistry, Mar-25, Volume: 47, Issue:7
Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
AID214374Inhibition of porcine brain tubulin assembly at 40 uM2004Journal of medicinal chemistry, Mar-25, Volume: 47, Issue:7
Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
AID522811Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID156322In vitro cytotoxicity against mouse PC3 prostate cancer cell line.2004Journal of medicinal chemistry, Mar-25, Volume: 47, Issue:7
Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
AID522808Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID537681Antileishmanial activity against Leishmania donovani2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
QSAR and docking studies of novel antileishmanial diaryl sulfides and sulfonamides.
AID522810Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID101194Percentage inhibition against Leishmania tubulin in vitro was determined at 20 uM2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin.
AID214974Inhibitory concentration against brucei variant 221 was determined in vitro2004Journal of medicinal chemistry, Mar-25, Volume: 47, Issue:7
Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
AID111481Tested against Trypanosoma brucei strain ST1B 795 in mice as cured to tested at 20 mg/kg/day administered intraperitoneally; 0/42004Journal of medicinal chemistry, Mar-25, Volume: 47, Issue:7
Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
AID496818Antimicrobial activity against Trypanosoma brucei brucei2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID117771Average survival time for mice infected with Trypanosoma brucei ST1B 795 when treated with 20 mg/kg administered i.p.2004Journal of medicinal chemistry, Mar-25, Volume: 47, Issue:7
Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
AID522809Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID522806Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID522816Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID496828Antimicrobial activity against Leishmania donovani2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID522805Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID100414Inhibitory activity against Leishmania donovani promastigotes2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin.
AID502117Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay2010Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17
Synthesis and evaluation of oryzalin analogs against Toxoplasma gondii.
AID522812Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID213844Inhibition percentage of Leishmanial tubulin assembly at a concentration of 10 uM.2004Journal of medicinal chemistry, Mar-25, Volume: 47, Issue:7
Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
AID522813Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID91776In vitro cytotoxicity against mouse J774 macrophages.2004Journal of medicinal chemistry, Mar-25, Volume: 47, Issue:7
Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
AID522807Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID522814Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID1799579In Vitro Activity Assay from Article 10.1111/j.1747-0285.2008.00729.x: \\Inhibitors of tubulin assembly identified through screening a compound library.\\2008Chemical biology & drug design, Dec, Volume: 72, Issue:6
Inhibitors of tubulin assembly identified through screening a compound library.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (55.56)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.05 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]